CLEMASTINA - SOL INJ 1 mg / ml IM / IV - 2 ml

ID 3501591 · Portal BASE
Price
Base Price
€4,854 .00
Effective Price
€658 .00 -86.4%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33000000
Location
Portugal, Évora
Bidder Count
—
Winner
GlaxoSmithKline Consumer Healthcare
NIF 500276994
Company
Dates
Publication
10 Jul 2017
Celebration
28 Sep 2015
Contracting Entity
ARS Alentejo, IP
NIF 503148768
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 135 · CRITICAL RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
40
Supplier
353
Number of Awards
4
Rule
A1 repeat direct award: 4 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
10 Jul 2017
Signing Date
28 Sep 2015
Days Late
651
Rule
A2/A3 late publication: 651 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
4854.0
Threshold
5000.0
Rule
A5 threshold splitting: price within 5% below 5000.0
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
4854.0
Total effective price
658.0
Ratio
0.1356
Direction
reduction
Rule
A9 price reduction: ratio 0.1356 outside [0.5, 1.5]
Detected 2026-03-06